Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2023-12-29 Capital/Financing Update
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
Prospectus (non pricing) supplement (ATM) – English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'Pricing Supplement No. 3701' related to a short form base shelf prospectus and prospectus supplement dated March 4, 2022. It details the terms, conditions, risks, and pricing of a specific structured note offering by The Bank of Nova Scotia. The content includes detailed information about the securities being offered, their features, risks, pricing, and legal disclaimers. This type of document is a pricing supplement to a prospectus, which is a capital markets offering document related to fundraising and issuance of securities. It is not a financial report, earnings release, management discussion, or regulatory filing. It is a detailed capital/financing update describing a new debt security issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing. Confidence is high due to the explicit nature of the document as a pricing supplement for a securities offering.
2023-12-29 English
Auditors' consent letter.pdf
Audit Report / Information Classification · 95% confidence The document is a letter from PricewaterhouseCoopers LLP addressed to multiple Canadian securities commissions. It provides consent for the use of their audit report dated March 7, 2023, on the consolidated financial statements of Profound Medical Corp. for the years ended December 31, 2022 and 2021. The letter explicitly states it is a consent to use the auditor's report in a prospectus supplement related to the sale and issue of common shares. The document does not contain the financial statements themselves or detailed financial data, but rather the auditor's consent to incorporate their report by reference. The document length is short (2689 characters), and it is primarily an auditor's consent letter, not the audit report or the annual report itself. According to the Certification Rule and the Menu vs Meal Rule, such a document should be classified as an Audit Report / Information (AR) because it is a standalone audit-related document, not a full annual report or a regulatory filing. Therefore, the appropriate classification is AR with high confidence. FY 2022
2023-12-29 English
Underwriting or agency agreements (or amendment thereto).pdf
Capital/Financing Update Classification · 100% confidence The document is titled 'UNDERWRITING AGREEMENT' and details an agreement between Profound Medical Corp. and underwriters for a public offering of common shares. It includes definitions and terms related to securities law, underwriting, and the offering process. There is no indication that this is a financial report, earnings release, or management discussion. Instead, it is a legal and contractual document related to capital raising through an underwriting process. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2023-12-29 English
News release - English.pdf
Regulatory Filings
2023-12-28 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a proposed public offering of common shares by Profound Medical Corp. It details the offering terms, the intended use of proceeds, and regulatory filing intentions (e.g., filing a preliminary prospectus supplement and registration statement with the SEC). The document does not contain financial statements, detailed financial analysis, or management discussion of results. It is primarily an announcement of a capital raising event. Therefore, it fits the category of Capital/Financing Update (CAP). The document length (9270 characters) is sufficient to provide substantive information about the offering, not just a brief notice or link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2023-12-27 English
Draft shelf prospectus supplement – English.pdf
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement related to a short form base shelf prospectus for a public offering of common shares by Profound Medical Corp. It includes detailed information about the offering, underwriting agreement, listing, pricing, and legal disclaimers. The text references securities regulatory authorities, the U.S. SEC, and Canadian securities commissions, and discusses the offering process and related legal matters. This type of document is a capital raising disclosure, specifically a prospectus supplement, which fits the category of Capital/Financing Update (CAP). It is not an annual or interim report, earnings release, or any other category. The document length is substantial and contains detailed offering information, not just an announcement or a brief summary, confirming it is a financing update.
2023-12-27 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.